Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from JNJ

Unusual Options Activity in Johnson & Johnson Post Its Kenvue Spinoff Highlights Its Value

An unusual number of out-of-the-money put options in Johnson & Johnson come after the Aug. 30 spinoff of its consumer Kenvue business. This could be a good income play for short-put traders.

3 Pharma Stocks to Consider Prescribing to for Quality

3 Pharma Stocks to Consider Prescribing to for Quality

The pharmaceutical industry is expected to thrive amid robust demand and technological advancements. Given the solid long-term prospects of the industry, investors should consider buying quality stocks, Johnson & Johnson (JNJ), AstraZeneca (AZN), and Dr. Reddy’s Laboratories (RDY). Read on.

Is Johnson & Johnson (JNJ) a Buy Before September Begins?

Is Johnson & Johnson (JNJ) a Buy Before September Begins?

Pharma giant Johnson & Johnson (JNJ) has posted robust second-quarter results and raised its full-year outlook. Should investors look into the stock before September begins? Let’s look at its financial metrics to gauge its prospects….

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

3 Pharma Stocks With Promising Pipelines

The pharma industry is anticipated to stay buoyed in the years to come with consistent medical breakthroughs and rising need to serve an aging population. Therefore, pharma stocks Johnson & Johnson (JNJ), Novartis AG (NVS), and Dr. Reddy's Laboratories (RDY), which possess promising pipelines, could be wise portfolio additions now.…

3 Dividend Kings To Buy And Hold Forever in a Retirement Portfolio

Looking for ideas in your financial freedom or retirement portfolio? Here's 3 stocks that fit the bill.

3 Pharma Stock Buys You Don’t Want to Miss

The pharmaceutical industry is growing amid robust demand. Also, given that healthcare stocks are generally thought of as defensive investments, fundamentally strong Johnson & Johnson (JNJ), Novo Nordisk (NVO), and AstraZeneca (AZN) might be profitable buys now. Read on.

2 Must-Have Pharma Stocks to Buy in August, 1 to Sell

The pharmaceutical industry is poised to thrive amid increasing global healthcare demand. Hence, two quality pharma stocks, Johnson & Johnson (JNJ) and Novartis AG (NVS), could be solid portfolio additions. However, avoiding fundamentally weak stock SNDL Inc. (SNDL) could be a wise choice. Read more.

inkl

Read news from The Economist, FT, and more,
with one subscription

Is Johnson & Johnson (JNJ) a Must-Buy Stability Stock?

Is Johnson & Johnson (JNJ) a Must-Buy Stability Stock?

Thanks to the company’s solid first-quarter performance and growing pharmaceutical demand, Johnson & Johnson’s (JNJ) long-term prospects look bright. However, could the company ensure stability for investors amid the current market volatility? Keep reading….

Top 3 Pharma Stocks You Can’t Miss out On

Top 3 Pharma Stocks You Can’t Miss out On

The ever-transforming pharmaceuticals sector is ready to seize the opportunity to address the growing demand for healthcare across the globe. Therefore, adding these three quality pharma stocks, Johnson & Johnson (JNJ), Eli Lilly and Company (LLY), and Dr. Reddy's Laboratories (RDY), to your portfolio could prove to be beneficial. Read…

J&J Stock Roars Higher, Retaking Its 200-Day Line As Small Drugs Drive Big Beat

J&J Stock Roars Higher, Retaking Its 200-Day Line As Small Drugs Drive Big Beat

Johnson & Johnson beat quarterly expectations Thursday, helped by its new cancer drug Carvykti, and JNJ stock surged.

Investors Business Daily

Dow Jones Gains, Nasdaq Slides In Earnings Rush; Tesla Falls For 'Silly' Reason

Dow Jones Gains, Nasdaq Slides In Earnings Rush; Tesla Falls For 'Silly' Reason

Stocks opened mixed as earnings season stepped up. Tesla sank as Elon Musk said margin concerns will "look silly." Netflix, Taiwan Semi, United Airlines were key earnings movers too.

Investors Business Daily

Which Pharma Stock Is the Better July Pick: Johnson & Johnson (JNJ) or Curaleaf Holdings (CURLF)?

Which Pharma Stock Is the Better July Pick: Johnson & Johnson (JNJ) or Curaleaf Holdings (CURLF)?

On the backs of increasing medical requirements amid the soaring incidence of chronic diseases, the pharmaceutical industry’s outlook radiates promise. Given this backdrop, let us compare pharma stocks Johnson & Johnson (JNJ) and Curaleaf Holdings (CURLF) to discover which one of these could be worth buying in July. Read on….

3 Medical Stock Picks for Investors

3 Medical Stock Picks for Investors

As the demand for healthcare products and solutions continues to rise, the medical industry is poised for remarkable growth. Therefore, quality medical stocks Johnson & Johnson (JNJ), AstraZeneca (AZN), and Astellas Pharma (ALPMY) could be the ideal investments for your portfolio amid current market uncertainties. Read on….

3 Dividend Kings to Buy if Times Get Tough

3 Dividend Kings to Buy if Times Get Tough

The United States has yet to enter a recession, but even if we continue in this downturn or come out of it, these three Dividend Kings are top performers to consider.

Get all your
news in one place.

100’s of premium titles.
One news app.

Johnson & Johnson (JNJ) and SNDL Inc. (SNDL) -- Buy or Sell?

Investing in healthcare stocks could help hedge against economic downturns. Thus, Johnson & Johnson (JNJ) could be worth buying. However, I think SNDL (SNDL) is best avoided considering its weak fundamentals. Read on.

Johnson & Johnson Spins Off Kenvue in Biggest IPO Haul Since 2021

Johnson & Johnson rips off Band-Aid and spits out Listerine in a bid to boost margins.

The Fed Is About To Raise Rates! Get Ready To Plan Your Next Move!

Here Are 2 Ideas Depending on How the Next Fed Announcement Goes.

Investors Business Daily

The Surprising Source Of Johnson & Johnson's First-Quarter Beat And Raise

Johnson & Johnson beat first-quarter expectations Tuesday and raised its full-year outlook. But JNJ stock ended the trading day lower.

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Are Keeping This Healthcare Stock Long-Term

Despite an uncertain macro environment, healthcare giant Johnson & Johnson (JNJ) reported outstanding results in 2022, reflecting its business segments' continued strength. Moreover, the company has a history of increasing dividends for 60 consecutive years. Given its sustained business momentum and steady dividend payments, investors seem to stay committed to…

Investors Business Daily

Johnson & Johnson Pops After Sweetening Its Talc Settlement By Nearly $7 Billion

J&J reached an $8.9 billion settlement in ongoing litigation over its talc-based baby powders, leading JNJ stock to rise Wednesday.

Here's 3 Dividend Companies That Just Crossed Above Their 50 Moving Average

Trading Smarter, Not Harder With the 50-Day Moving Average Strategy

Investors Business Daily

Dow Jones Futures: AI Stock Keeps Sliding; Johnson & Johnson Rises

Futures: The indexes held up OK Tuesday amid recession fears, but breadth was weak. AI stock C3.ai kept falling overnight. J&J stock rose..

Investors Business Daily

J&J Drops Out Of A Key Race, Leaving Pfizer, GSK, Moderna To Duke It Out

Johnson & Johnson ducked out of the RSV vaccine race Wednesday, leaving Pfizer, GSK and Moderna to duke it out.

3 Popular Large-Cap Stocks to Buy Right Now

As investors continue to digest the news of the recent bank collapses and the Federal Reserve’s quarter-percentage-point rate hike, the stock market outlook seems bumpy for some time. With speculations of an economic slowdown, investing in prominent large-cap stocks Johnson & Johnson (JNJ), Visa (V), and Merck & Co. (MRK)…

3 Large-Cap Pharma Stocks to Protect Your Portfolio Through 2023

The worst banking crisis since 2008 could not stop the Fed from raising the benchmark interest rate. The possibility of further policy tightening and strict lending standards for banks might push the economy into a recession this year. Therefore, investing in large-cap pharma stocks Johnson & Johnson (JNJ), Merck &…

People

Dipanjan BanchurSince

Steve Reitmeister

Sristi Suman JayaswalThe

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

US Federal Reserve

United Airlines

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

312,742 stories

The United States

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play